MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Location

Founded

1989-12-19

Risk Signals

4960 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Live alerts from global media, monitored by Business Radar

Twin Cities executive convicted of insider trading involving company’s acquisition by Medtronic

2024-02-21 (twincities.com)

Twin Cities executive convicted of insider trading involving company’s acquisition by Medtronic

An executive at a Twin Cities medical device company has been convicted of insider trading for a scheme involving negotiations for the acquisition of the firm that was valued at $1.6 billion, feder...

Read more
Stryker faces another bribery investigation

2023-05-04 (massdevice.com)

Stryker faces another bribery investigation

Stryker says the U.S. Justice Dept. and Securities and Exchange Commission contacted the company over potential antibribery law violations.

Read more
Better Dividend Stock: Abbott Laboratories or Medtronic?

2023-02-27 (fool.com)

Better Dividend Stock: Abbott Laboratories or Medtronic?

One of these top dividend stocks is a far more compelling buy today.

Read more
Former business VP charged with insider trading, securities fraud in $1.6 billion buyout of Mazor by Medtronic

(dotmed.com)

Former business VP charged with insider trading, securities fraud in $1.6 billion buyout of Mazor by Medtronic

Committed crimes over a two-year period

Read more
Smith+Nephew records $5.5B in 2023 revenue

(beckersspine.com)

Smith+Nephew records $5.5B in 2023 revenue

Discover the impressive growth of medtech company Smith+Nephew as they surpass $5 billion in 2023 revenue.

Read more
Aclarion announces $3M public offering

(beckersspine.com)

Aclarion announces $3M public offering

Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.

Read more
Former NuVasive, LimaCorporate exec to lead Orthofix

(beckersspine.com)

Former NuVasive, LimaCorporate exec to lead Orthofix

Orthofix named Massimo Calafiore as its new president and CEO.

Read more
Lucas Buchanan Joins Endologix Board of Directors

(mpo-mag.com)

Lucas Buchanan Joins Endologix Board of Directors

Buchanan is currently CFO and chief operating officer at Silk Road Medical Inc.

Read more

Never miss a headline about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages